This was the stock's second consecutive day of gains.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report). The company’s shares closed yesterday at $104.03.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

Employees at the National Cancer Institute, which is part of the National Institutes of Health, received internal guidance last week to flag manuscripts, presentations or other communications for ...

Hans Zimmer opened up about the Academy disqualification of his Dune: Part Two score for Oscars consideration, calling the ruling “stupid.” In a conversation with Josh Horowitz on his Happy ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cooper Co (COO – Research Report) and Zimmer Biomet Holdings (ZBH – Research Report). See what stocks are ...

WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA ...

The Persona Knee system. [Image courtesy of Zimmer Biomet] Zimmer Biomet (NYSE: ZBH) + announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur. The revision ...